Add BrightSurf on Google Email

Releasing “brakes” in the brain

A team of researchers used deep brain stimulation to localize disrupted neural pathways in patients with Parkinson's disease, dystonia, OCD, and Tourette's syndrome. The study identified specific brain circuits associated with each disorder, revealing overlapping malfunctions that suggest a complex network of brain dysfunctions.

SourceCharité - Universitätsmedizin Berlin·JournalNature Neuroscience·TypeComputational simulation/modeling·DateFeb 22, 2024

One step forward, no steps back: new study advances understanding of dopamine’s role in movement

Researchers discover dopamine signals affect movement sequence length, shedding light on Parkinson's Disease symptoms and potential therapeutic targets. The study's findings suggest a complex role of dopamine neurons in movement, with distinct effects on movement-related and reward-related dopamine neurons.

SourceChampalimaud Centre for the Unknown·JournalCurrent Biology·TypeExperimental study·DateFeb 19, 2024

The Medical University of South Carolina will be one of four sites exploring the genetic basis of Parkinson’s disease in the Black community

The Medical University of South Carolina will be one of four sites exploring the genetic basis of Parkinson’s disease in the Black community. The study, known as BLAAC PD, aims to genotype over 150,000 people worldwide and develop targeted treatments for this subtype of PD.

SourceMedical University of South Carolina·TypeRandomized controlled/clinical trial·DateFeb 7, 2024

A neurological disease paradigm shift

Researchers at McGill University propose a new biological classification system for Parkinson's disease, considering alpha-synuclein, neurodegeneration, and genetics. This shift in thinking aims to diagnose the disease earlier, targeting specific patient groups with more common biology, improving treatment development success.

SourceMcGill University·JournalThe Lancet Neurology·TypeSystematic review·DateJan 23, 2024

Towards a new Parkinson's diagnosis: Introduction of the SynNeurGe biological diagnosis classification

A new biological classification system for Parkinson's disease, known as SynNeurGe (S-N-G system), has been introduced. This classification considers three key components: pathological α-synuclein in tissues or cerebrospinal fluid, neuroimaging techniques, and pathogenic gene variants. The S-N-G system offers a detailed framework for u...

SourceUniversity of Lübeck·JournalThe Lancet Neurology·TypeMeta-analysis·DateJan 22, 2024

Mount Sinai researchers identify diverse neuron types associated with vulnerability to Parkinson's disease

Researchers discovered a previously unreported neuron type with vulnerability in Parkinson's disease, shedding light on the complexity of the disease and potential therapeutic targets. The study identified distinct transcriptomic signatures of this neuron type and found reduced RIT2 expression in Parkinson's disease patients.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalScience Advances·TypeObservational study·DateJan 11, 2024

Inspired by Greek mythology, this potential drug shows promise for vanquishing Parkinson’s RNA in early studies

A potential Parkinson's medicine, Syn-RiboTAC, targets RNA to slow or stop disease progression by preventing the buildup of toxic protein alpha-synuclein. In early studies, reducing alpha-synuclein levels by even 25% or more is therapeutically beneficial, with the compound showing good selectivity and improved brain-barrier penetration.

SourceUF Health·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJan 9, 2024

Novel test holds promise for detecting Parkinson’s disease early

Researchers developed a novel test that detects single ⍺-synuclein fibrils in patient samples to identify patients with Parkinson's disease earlier. This breakthrough has the potential to create early applicable molecular diagnostics, improve clinical trials, and facilitate drug screening for neurodegenerative diseases.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJan 8, 2024

Can we fight back against Parkinson’s disease? These research volunteers hope so

Researchers at Boston University's Center for Neurorehabilitation have made two important advances that may help people with Parkinson's disease walk more smoothly. Wearable soft robotic apparel and a music-based technology were tested in studies, showing promising results in increasing walking duration and distance.

SourceBoston University·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateJan 5, 2024

Structures of Parkinson’s disease-linked proteins offer a framework for understanding how they work together

Scientists at St. Jude Children's Research Hospital have determined the complex structure of Parkinson’s disease-related proteins LRRK2 and Rab29, revealing how they work synergistically to cause the disease. The structures provide an atomic-scale map to trace how different mutations affect function within this complex, with implicatio...

Research from Duke-NUS’ GK Goh Centre for Neuroscience reveals novel ways of cultivating brain cells to treat and study neurodegenerative diseases

Scientists have successfully grown neurons from stem cells that can repair damaged brain tissue after stroke, offering new hope for treatments. The technology also holds promise for studying neurodegenerative diseases like Alzheimer's, Parkinson's, and spinal cord injury.

SourceDuke-NUS Medical School·JournalAdvanced Science·TypeExperimental study·DateDec 14, 2023

Repeated blast exposures may harm the brain health of military personnel

A study found increased brain inflammation and structural changes in special operations personnel exposed to blasts, potentially increasing the risk of long-term brain-related disease. The research suggests that repetitive exposure to low-level blasts may cause brain injuries and highlights the need for better protective measures.

SourceUniversity of Virginia Health System·JournalJournal of Neurotrauma·TypeRandomized controlled/clinical trial·DateDec 6, 2023

Scientists plead to be heard in pesticide debate: Exposure linked to risk of developing parkinson's disease via changes in gut microbiome

A review article links pesticide exposure to an increased risk of developing Parkinson's disease through alterations in the gut microbiota. The authors recommend reducing or replacing agrochemicals and implementing coordinated efforts to develop standardized biomarkers for gut integrity and microbiome changes.

SourceIOS Press·JournalJournal of Parkinson’s Disease·TypeSystematic review·DateDec 6, 2023

Unlocking the secrets of the brain’s dopaminergic system

A new organoid model replicates the dopaminergic system's structure, connectivity, and functionality, shedding light on its intricate functionality and potential implications for Parkinson’s disease. The model also uncovers the enduring effects of chronic cocaine exposure on the dopaminergic circuit, even after withdrawal.

Scientists produce human norepinephrine neurons from stem cells, with significant implications for researching diseases like Alzheimer’s and Parkinson’s

Researchers at the University of Wisconsin-Madison have successfully generated human norepinephrine neurons from stem cells using a key protein called ACTIVIN-A. These LC-NE neurons may serve as models for disease in humans, enabling scientists to screen drugs and answer questions about neurodegeneration.

SourceUniversity of Wisconsin-Madison·JournalNature Biotechnology·DateNov 17, 2023

New study reveals molecular causes of rare neurological condition in children

A new study has uncovered the molecular causes of a rare developmental brain condition in children, known as Autosomal Recessive ACBD6-related disorder. The research team identified defects in the acyl-CoA-binding domain-containing protein 6 (ACBD6) gene as the underlying cause, leading to delays in cognitive and motor skills development.

SourceUniversity of Portsmouth·JournalBrain·TypeExperimental study·DateNov 16, 2023

C-Path’s pioneering neuroscience workshop transforms the landscape of neurological disorder therapies

The C-Path Neuroscience Annual Workshop brought together stakeholders to chart a transformative course for neurology research and drug development, focusing on chronic progressive diseases such as Alzheimer's and Parkinson's. Key highlights included recommendations for innovative therapies and tools to address complex disorders.

SourceCritical Path Institute (C-Path)·JournalNeurotherapeutics·TypeContent analysis·DateNov 9, 2023

PET scans may predict Parkinson’s disease and Lewy body dementia in at-risk individuals

Researchers used PET scans to detect low cardiac norepinephrine levels in individuals with Parkinson's risk factors, finding that those with low radioactivity were highly likely to develop Parkinson's or Lewy body dementia. The study suggests a potential biomarker for early detection and treatment of these diseases.

SourceNIH/National Institute of Neurological Disorders and Stroke·JournalJournal of Clinical Investigation·TypeObservational study·DateNov 7, 2023

Parkinson disease and normal aging

Researchers investigate centro-cingulate network changes and cholinergic innervation deficits in Parkinson disease and normal aging. Studies reveal significant correlations between centro-cingulate changes and cognitive impairments, motor symptoms, and age.

SourceImpact Journals LLC·JournalAging-US·TypeCommentary/editorial·DateNov 1, 2023

Tai Chi may curb Parkinson’s disease symptoms and complications for several years

Research suggests that Tai Chi practice can slow Parkinson's disease progression, improve non-motor symptoms, and lower medication needs over time. The study found significant benefits in disease severity, cognitive function, sleep quality, and complication prevalence in the Tai Chi group compared to the standard care group.

SourceBMJ Group·JournalJournal of Neurology Neurosurgery & Psychiatry·TypeObservational study·DateOct 24, 2023

Molecular age of the eye determined for the first time

A team of researchers has created a 'proteomic clock' that can predict a healthy person's age based on their protein profile, revealing accelerated aging due to diseases. The study also detected proteins associated with Parkinson's disease in eye fluid, offering a potential pathway for earlier diagnoses.

SourceCell Press·JournalCell·TypeExperimental study·DateOct 19, 2023

Microbial metabolites: A new link to Parkinson's disease?

A recent study by the University of Vienna and collaborators suggests that microbial metabolites may play a role in inducing Parkinson's-like symptoms. The researchers identified a specific bacterial metabolite that selectively damages dopamine-producing neurons, mirroring the neuronal loss observed in Parkinson's disease.

SourceUniversity of Vienna·JournalEnvironment International·DateOct 10, 2023

Loneliness and risk of Parkinson disease

A large study of 491,000 participants found that loneliness was associated with an increased risk of developing Parkinson's disease. The findings suggest that loneliness is a significant psychosocial determinant of health and may contribute to the development of the neurodegenerative disorder.

SourceJAMA Network·JournalJAMA Neurology·DateOct 2, 2023